Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PPD Names VP of Clinical Development for Asia-Pacific | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

PPD Names VP of Clinical Development for Asia-Pacific

Will run Phase II-IV business in region

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Edward Ian has been named PPD‘s vice president of clinical development for Asia-Pacific. Mr. Ian will be based in Singapore and will provide strategic leadership and operational oversight for PPD’s Phase II-IV business in the region.

“Edward Ian brings more than 15 years of clinical operations, central laboratory management, quality management systems and project management expertise through his long tenure with multinational companies in Asia-Pacific and the U.S.,” said Paul Colvin, executive vice president of global clinical development at PPD. “His expertise across a wide range of areas within the clinical research industry will play a significant role in advancing our strong position in this growing region.”

Mr. Ian spent six years at PRA International, where he most recently served as executive director of scientific affairs responsible for Phase I-IV clinical operations in Asia-Pacific. He also held the positions of regional director of operations and senior director of clinical operations for Asia-Pacific, where he managed daily operations, set strategy and performance standards, and collaborated on business development initiatives. He began his career as a laboratory scientist and later served as director of business development and quality assurance for a regional CRO in Taiwan where he rose to executive vice president.

PPD’s Asia-Pacific operations include nearly 1,400 people and offices in 13 countries. The company offers a full range of drug discovery and development services from the region, including operating global central laboratories in China and Singapore.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics